Search Results - "Giedraitienė, Nataša"
-
1
Chronotypes and their relationship with depression, anxiety, and fatigue among patients with multiple sclerosis in Vilnius, Lithuania
Published in Frontiers in neurology (27-11-2023)“…Approximately half of patients with multiple sclerosis (PWMS) experience sleep disorders or changes in the circadian rhythm, that may further promote the…”
Get full text
Journal Article -
2
Detection of aquaporin‐4 antibodies for patients with CNS inflammatory demyelinating diseases other than typical MS in Lithuania
Published in Brain and behavior (01-11-2018)“…Objectives Neuromyelitis optica (NMO) is frequently associated with aquaporin‐4 autoantibodies (AQP4‐Ab); however, studies of NMO in Lithuania are lacking…”
Get full text
Journal Article -
3
The BICAMS Battery for Assessment of Lithuanian-Speaking Multiple Sclerosis Patients: Relationship with Age, Education, Disease Disability, and Duration
Published in Medical science monitor (10-12-2015)“…BACKGROUND Assessment of cognitive impairment (CI) in multiple sclerosis (MS) patients is very useful, but it requires time-consuming expert evaluation with…”
Get full text
Journal Article -
4
Distinctive Pattern of Cognitive Disorders During Multiple Sclerosis Relapse and Recovery Based on Computerized CANTAB Tests
Published in Frontiers in neurology (04-06-2019)“…Cognition may be affected at least as seriously as physical function during multiple sclerosis (MS) relapse, however MS relapse related cognitive disorders are…”
Get full text
Journal Article -
5
Seroprevalence of neuronal antibodies in diseases mimicking autoimmune encephalitis
Published in Scientific reports (04-03-2024)“…Detection of neuronal antibodies for autoimmune encephalitis and paraneoplastic neurological syndromes relies on commercially available cell-based assays and…”
Get full text
Journal Article -
6
Cognitive Decline in Multiple Sclerosis Is Related to the Progression of Retinal Atrophy and Presence of Oligoclonal Bands: A 5-Year Follow-Up Study
Published in Frontiers in neurology (13-07-2021)“…Background: Brain atrophy, which is associated with cognitive impairment and retinal nerve fiber layer (RNFL) atrophy, is the main biomarker of…”
Get full text
Journal Article -
7
Tumefactive demyelinating disorders as stroke mimics: Description of cases and systematic review of the literature
Published in Multiple sclerosis and related disorders (01-08-2023)“…tumefactive multiple sclerosis (TmMS) is a rare subtype of a demyelinating disease that develops over time. Cases of hyperacute presentations mimicking…”
Get full text
Journal Article -
8
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study
Published in Multiple sclerosis (01-05-2022)“…Background: Ofatumumab, the first fully human anti-CD20 monoclonal antibody, is approved in several countries for relapsing multiple sclerosis (RMS)…”
Get full text
Journal Article -
9
Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
Published in Medical science monitor (01-02-2017)“…BACKGROUND With the advent of numerous new-generation disease-modifying drugs for multiple sclerosis (MS), the discrimination between relapsing-remitting MS…”
Get full text
Journal Article -
10
Cognition During and After Multiple Sclerosis Relapse as Assessed With the Brief International Cognitive Assessment for Multiple Sclerosis
Published in Scientific reports (25-05-2018)“…There is some evidence that cognition may be impaired during multiple sclerosis (MS) relapse. The aims of this study were to assess the cognitive status with…”
Get full text
Journal Article -
11
Epidemiological analysis of paraneoplastic neurological syndromes and autoimmune encephalitides in Vilnius County, Lithuania
Published in Journal of the neurological sciences (01-12-2023)Get full text
Journal Article -
12
Autologous hematopoietic stem cell transplantation is superior to alemtuzumab in patients with highly active relapsing multiple sclerosis and severe disability
Published in Multiple sclerosis and related disorders (01-12-2023)“…•Fewer relapses are established after HSCT than ATZ treatment.•ATZ may halt disability progression early in the course of highly active RMS.•After HSCT gradual…”
Get full text
Journal Article -
13
Therapeutic Plasma Exchange in Multiple Sclerosis Patients with Abolished Interferon-beta Bioavailability
Published in Medical science monitor (26-05-2015)“…Neutralizing antibodies (NAb) to interferon-beta (IFN-β) are associated with reduced bioactivity and efficacy of IFN-β in multiple sclerosis (MS). The…”
Get full text
Journal Article